Pathophysiology of restless legs syndrome - The present state of research;Pathophysiologie des restless-legs-syndroms: Aktueller stand der forschung

Nervenarzt

Volumn 72, Issue 2, 2001, Pages 100-107

  Winkelmann, J ^a   Trenkwalder, C ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Pahtophysiology; Restless legs syndrome; Sleep

Indexed keywords

OPIATE RECEPTOR;

BRAIN DEPTH STIMULATION; BRAIN STEM; CIRCADIAN RHYTHM; DIAGNOSTIC PROCEDURE; DOPAMINERGIC TRANSMISSION; NEUROTRANSMISSION; PATHOPHYSIOLOGY; RESTLESS LEGS SYNDROME; REVIEW; SLEEP;

ADULT; CHRONOBIOLOGY DISORDERS; DOPAMINE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NOCTURNAL MYOCLONUS SYNDROME; RESTLESS LEGS SYNDROME; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; UREMIA;

EID: 0035117077     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050721     Document Type: Review

References (89)

1. Restless legs syndrome treatment with dopaminergic drugs
2. Augmentation of the restless legs syndrome with carbidopa/levodopa
3. Recording and scoring leg movements
4. Periodic limb movements in sleep: State-dependent excitability of the spinal flexor reflex
5. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: A double-blind, controlled study
6. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
7. Cerebral generators involved in the pathogenesis of the restless legs syndrome
8. Reflex studies and MRI in the restless legs syndrome
9. Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome
10. Clinical and biochemical findings in uremic patients with and without restless legs syndrome
11. Circadian endocrine rhythms in restless legs syndrome
12. Autosomal dominant restless legs syndrome: Genetic model and evaluation of 22 candidate genes
13. RLS patients have abnormally reduced CSF ferritin compared to normal controls
14. Restless legs
15. Changes in excitability of motor cortical circuitry in primary restless legs syndrome
16. The Babinski reflex during sleep and wakefulness
17. Charcot-Marie-Tooth disease type 2 with restless legs syndrome
18. Cryoglobulinaemic neuropathy manifesting with restless legs syndrome
19. The diurnal variation in perception of pain
20. Restless leg syndrome in pregnancy
21. Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders
22. Restless legs syndrome associated with spinal cord lesions
23. Restless legs syndrome after a borrelia-induced myelitis
24. Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: Treatment with opioids
25. Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome
26. The treatment of restless legs syndrome and periodic limb movement disorder
27. Evidence of peripheral axonal neuropathy in primary restless legs syndrome
28. Restless legs syndrome and sleep bruxism: Prevalence and association among Canadians
29. Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees
30. Sleep-related periodic leg movements associated with spinal cord lesions
31. Nocturnal myoclonus and restless legs syndrome
32. Restless legs, anxiety and caffeinism
33. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg and periodic leg movements in sleep for the diagnosis of restless leg syndrome
34. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria
35. Familial restless legs with periodic movements in sleep: Electrophysiologic, biochemical, and pharmacologic study
36. Restless legs syndrome and periodic movements in sleep: The primary role of dopaminergic mechanism
37. Somatosensory and brainstem auditory evoked responses in sleep-related periodic leg movements
38. Chronobiology of serum iron concentration in subjects of different ages at different geographic locations
39. Periodic limb movements in syringomyelia and syringobulbia
40. Iron status and restless legs syndrome in the elderly
41. Restless legs syndrome: Clinicoetiologic correlates
42. Epidemiology of Restless legs symptoms in adults
43. Effect of pergolide on restless legs and movements in sleep in uremic patients
44. Possible relation between restless legs and anaemia in renal dialysis patients
45. The R3 component of the blink reflex in man: A reflex response induced by activation of high threshold artaneous afferents
46. Prevalence and risk factors of RLS in an elderly population: The MEMO study
47. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome
48. Restless legs syndrome in patients with poly-neuropathy
49. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis
50. Restless legs syndrome a nd nocturnal myoclonus: Initial clinical manifestation of familial amyloid polyneuropathy
51. Opioid receptors in the human cerebellum: Evidence from (11C) diprenorphine PET, mRNA expression and autoradiography
52. Sleep disturbances in spino-cerebellar ataxias
53. Analysis of L-Dopa actions on nociceptive and non-nociceptive spinal reflex pathways in the cat
54. Striatal dopamine transporter binding assessed by I-123 IPT and single photon emission computed tomography in patients with early Parkinson's disease
55. Relationship of periodic movements in sleep (nocturnal myoclonus) and the Babinski sign
56. Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration
57. Impairment of cortical inhibition in restless legs syndrome - Shortening of silent period induced by transcranial magnetic stimulation
58. Prolongation of shortened cortical silent period after transcranial magnetic stimulation in patients with idiopathic restless legs syndrome by levodopa
59. Iron and the restless legs syndrome
60. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with I-123 IPT and SPECT
61. Motor system excitability in patients with restless legs syndrome
62. Bereitschaftspotential in idiopathic and symptomatic restless legs syndrome
63. Electrophysiological pattern of involuntary limb movements in the restless legs syndrome
64. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome
65. Comparison of idiopathic and uremic restless legs syndrome: Results of a database of 134 patients
66. Clinical symptoms and possible anticipation in familial restless legs syndrome
67. L-DOPA therapy of uremic and idiopathic restless legs syndrome: A double-blind crossover trial
68. Positron emission tomographic studies in restless legs syndrome
69. Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions
70. Striatal dopaminergic function in restless legs syndrome. 18F-dopa and 11C-raclopride PET studies
71. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas: A PET study
72. Periodic limb movements during sleep in restless legs syndrome: An electrophysiological study of the motor pattern
73. L-DOPA/Carbidopa for nocturnal movement disorders in uremia
74. Dominantly inherited restless legs with myoclonus and periodic movements of sleep: A syndrome related to endogenous opiates?
75. A questionnaire study of 138 patients with restless legs syndrome: The "Night-Walkers" survey
76. Towards a better definition of the restless legs syndrome
77. Variable expressivity in familial restless legs syndrome
78. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo
79. Nocturnal myoclonus and tricyclic antidepressants
80. Periodic leg movements of sleep (nocturnal myoclonus): An electrophysiological study
81. Iodine-123-IPT SPECT imaging in idiopathic restless legs syndrome: Preliminary findings
82. Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome
83. A randomized controlled study of pergolide in patients with restless legs syndrome
84. Restless legs syndrome in end-stage renal disease
85. Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients
86. Periodic limb movements and restless legs syndrome in syringo-myelia
87. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients
88. Restless legs syndrome treated successfully by kidney transplantation-a case report
89. Sleep-related periodic leg movements (nocturnal myoclonus) due to spinal cord lesion